Results 31 to 40 of about 7,485,897 (373)
Electronics, 2020 From the last decade, pharmaceutical companies are facing difficulties in tracking their products during the supply chain process, allowing the counterfeiters to add their fake medicines into the market.
Khizar Abbas +3 more
semanticscholar +1 more source
The Dynamic Spillovers of Entry: An Application to the Generic Drug Industry
Management Sciences, 2018 This paper examines whether experience from entry in one market can potentially enhance profitability at a future market opportunity for a related product.
A. Gallant, H. Hong, Ahmed Khwaja
semanticscholar +1 more source
Potential therapies against SARS-CoV-2 virus evaluated in large-scale clinical trials [PDF]
Romanian Journal of Pharmaceutical Practice, 2022 COVID-19 is a viral disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The pathogenesis of SARS-CoV-2 infection in humans manifests as mild symptoms to severe respiratory failure.
Alin-Viorel Focsa +4 more
doaj +1 more source
Hydrophilic Matrices for Oral Control Drug Delivery [PDF]
, 2015 Oral controlled drug delivery has gathered tremendous attention over the years due to its many advantages over conventional dosage forms. Polymer-based matrices have become an integral part of the pharmaceutical industry. Hydrophilic matrices are capable
Conway, Barbara R, Ghori, Muhammad U.
core +1 more source
Pharmaceutical Fronts, 2022 This study aims to identify the chemical components in Sophorae Fructus, and explore the mass spectrometric cleavage rules using the UPLC-Q-TOF-MS/MS method. The main characteristic fragments of the compounds were analyzed by electrospray ionization (ESI)
Zi-Hui He +3 more
doaj +1 more source
Using transcriptomics to guide lead optimization in drug discovery projects : lessons learned from the QSTAR project [PDF]
, 2015 The pharmaceutical industry is faced with steadily declining R&D efficiency which results in fewer drugs reaching the market despite increased investment.
Bender, Andreas +10 more
core +2 more sources
Pharmaceutical Fronts, 2020 Adalimumab, a full-length monoclonal antibody, is widely used as an anti-tumor necrosis factor-α (anti-TNF-α) agent. In this article, we aimed to prolong the in vivo half-life of adalimumab antigen-binding fragment (Fab) through Sortase A (SrtA)-mediated
Qing-Bin Zhang +5 more
doaj +1 more source
Recent Research Advances in Small-Molecule Pan-PIM Inhibitors
Pharmaceutical Fronts, 2022 PIM kinase is consequently emerging as a promising target for cancer therapeutics and immunomodulation. PIM kinases are overexpressed in a variety of hematological malignancies and solid tumors, and their inhibition has become a strong therapeutic ...
Lei Xu +5 more
doaj +1 more source
Making regulation responsive to commercial interests: streamlining drug industry watchdogs [PDF]
, 2002 New prescription drugs are developed and tested for quality, safety, and efficacy by the pharmaceutical industry, and little or no drug testing is conducted by governments in modern industrialised countries.
Abraham, John
core +2 more sources